AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionBroadleaf Partners, LLC
Latest Disclosed Ownership4,787 shares
Latest Disclosed Value $ 1,041,125
Broadleaf Partners, LLC ownership in 4AB / AbbVie Inc.

On May 14, 2026 - Broadleaf Partners, LLC filed a 13F-HR form disclosing ownership of 4,787 shares of AbbVie Inc. (BG:4AB) valued at $1,041,125 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 4,787 shares of AbbVie Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F Abbvie COM 00287Y109 4,787 0 0.00 1,041 -4.76 0.2427
2026-02-13 2025-12-31 13F Abbvie COM 00287Y109 4,787 0 0.00 1,094 -1.35 0.2307
2025-11-13 2025-09-30 13F Abbvie COM 00287Y109 4,787 -31 -0.64 1,108 23.94 0.2311
2025-08-14 2025-06-30 13F Abbvie COM 00287Y109 4,818 -945 -16.40 894 -25.93 0.1969
2025-05-14 2025-03-31 13F ABBVIE COM 00287Y109 5,763 -1,800 -23.80 1,207 -10.13 0.3162
2025-02-13 2024-12-31 13F ABBVIE COM 00287Y109 7,563 -335 -4.24 1,344 -13.86 0.3139
2024-11-12 2024-09-30 13F ABBVIE COM 00287Y109 7,898 0 0.00 1,560 15.14 0.3690
2024-08-12 2024-06-30 13F ABBVIE COM 00287Y109 7,898 -10 -0.13 1,355 -5.97 0.3277
2024-05-14 2024-03-31 13F ABBVIE COM 00287Y109 7,908 10 0.13 1,440 17.74 0.3691
2024-02-13 2023-12-31 13F Abbvie COM 00287Y109 7,898 0 0.00 1,224 3.91 0.3588
2023-11-13 2023-09-30 13F Abbvie COM 00287Y109 7,898 -33 -0.42 1,177 10.21 0.3932
2023-08-11 2023-06-30 13F Abbvie COM 00287Y109 7,931 2,500 46.03 1,069 23.47 0.3487
2023-05-11 2023-03-31 13F Abbvie COM 00287Y109 5,431 0 0.00 866 -1.48 0.3086
2023-02-10 2022-12-31 13F Abbvie COM 00287Y109 5,431 0 0.00 878 20.44 0.3463
2022-11-08 2022-09-30 13F Abbvie COM 00287Y109 5,431 0 0.00 729 -12.38 0.3033
2022-08-09 2022-06-30 13F Abbvie COM 00287Y109 5,431 0 0.00 832 -5.45 0.3478
2022-05-11 2022-03-31 13F Abbvie COM 00287Y109 5,431 0 0.00 880 19.73 0.2932
2022-02-09 2021-12-31 13F Abbvie COM 00287Y109 5,431 0 0.00 735 25.43 0.2257
2021-11-09 2021-09-30 13F Abbvie COM 00287Y109 5,431 0 0.00 586 -4.25 0.1939
2021-07-15 2021-06-30 13F Abbvie COM 00287Y109 5,431 0 0.00 612 4.08 0.2127
2021-04-23 2021-03-31 13F Abbvie COM 00287Y109 5,431 0 0.00 588 1.03 0.2214
2021-02-24 2020-12-31 13F Abbvie COM 00287Y109 5,431 150 2.84 582 25.70 0.2297
2020-10-23 2020-09-30 13F Abbvie COM 00287Y109 5,281 0 0.00 463 -10.62 0.2040
2020-08-04 2020-06-30 13F Abbvie COM 00287Y109 5,281 0 0.00 518 28.86 0.2537
2020-05-05 2020-03-31 13F Abbvie COM 00287Y109 5,281 0 0.00 402 -14.10 0.2591
2020-01-31 2019-12-31 13F Abbvie COM 00287Y109 5,281 0 0.00 468 17.00 0.2562
2019-10-21 2019-09-30 13F Abbvie COM 00287Y109 5,281 -1,050 -16.59 400 -13.04 0.2500
2019-07-19 2019-06-30 13F Abbvie COM 00287Y109 6,331 0 0.00 460 -9.80 0.2943
2019-04-10 2019-03-31 13F/A-1 Abbvie COM 00287Y109 6,331 0 0.00 510 -12.67 0.3559
2019-04-09 2019-03-31 13F Abbvie COM 00287Y109 6,331 502
2019-01-15 2018-12-31 13F Abbvie COM 00287Y109 6,331 -45,103 -87.69 584 -88.00 0.4668
2018-10-12 2018-09-30 13F Abbvie COM 00287Y109 51,434 -629 -1.21 4,865 0.85 3.2632
2018-08-07 2018-06-30 13F/A-1 Abbvie COM 00287Y109 52,063 12,039 30.08 4,824 27.35 3.5345
2018-07-17 2018-06-30 13F Abbvie COM 00287Y109 104,126 64,102 9,647
2018-04-20 2018-03-31 13F Abbvie COM 00287Y109 40,024 5,107 14.63 3,788 12.17 2.9146
2018-01-12 2017-12-31 13F Abbvie COM 00287Y109 34,917 34,917 3,377 2.8047
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.